AnticoagEvaluator
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
為使房顫患者知情抗血栓治療的決定。
使抗血栓治療的非瓣膜性房顫患者更新AnticoagEvaluator消息靈通的決定。
使用應用程序來：
•計算患者的腎功能和缺血性中風，血栓栓塞風險，和流血
•用於預防中風審查ACC / AHA / HRS指南驅動的治療指導
•生成個性化的風險，根據個人的臨床試驗的抗血栓治療方案。
•提高準確運用DOACs的基於處方信息調整劑量，微調腎和其他病人的特點。
這個程序是基於SPARC的工具，由彼得·洛溫，ACPR，藥學博士，FCSHP，可在www.sparctool.com被視為開發